Convatec
Convatec Group Plc, headquartered in Great Britain, is a leading global medical technology company specialising in advanced wound care, ostomy care, continence and critical care, and infusion devices. Founded in 1978, Convatec has established itself as a pioneer in the healthcare industry, focusing on innovative solutions that enhance patient outcomes. With a strong presence in Europe, North America, and Asia-Pacific, Convatec offers a diverse range of products, including hydrocolloid dressings and advanced ostomy appliances, known for their quality and effectiveness. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted partner in healthcare. Convatec's dedication to improving the lives of patients and healthcare professionals alike underscores its reputation as a market leader in medical technology.
DitchCarbon Score
How does Convatec's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Convatec's score of 77 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Convatec's reported carbon emissions
In 2024, Convatec reported total carbon emissions of approximately 13,823,000 kg CO2e globally, with significant contributions from Scope 1 emissions at about 12,360,000 kg CO2e, Scope 2 emissions at approximately 1,463,000 kg CO2e, and a substantial Scope 3 total of about 239,255,000 kg CO2e, primarily from purchased goods and services (about 113,190,000 kg CO2e). In the UK, Scope 1 emissions for the same year were reported at approximately 2,702,000 kg CO2e. Convatec has set ambitious climate commitments, aiming for net zero emissions by 2045. The company has also committed to reducing absolute Scope 1 and 2 greenhouse gas emissions by 70% by 2030, using 2021 as the base year. Additionally, they plan to reduce Scope 3 emissions from purchased goods and services, upstream transportation, and waste generated in operations by 52% per sold product within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and reflect Convatec's commitment to addressing climate change within the healthcare equipment and supplies sector. The company’s strategic approach underscores its dedication to sustainability and reducing its overall carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 5,608,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 24,650,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Convatec is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
